CTRI/2024/01/061205尚未招募2 期
Randomised controlled clinical trial to compare the effect of yavani churn and vidlavan with gudharitaki yog in the management of shushka arsha - NI
Tilak Ayurveda Mahavidyalaya0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients having textual symptom of pain in Shushka Arsh( haemorrhoids) will be taken as subject to
- •These criterions will be before treatment included in this study.
- •Haemorrhoid patient all position and 1 and 2 degree Internal haemorrhoids, External
- •Haemorrhoids
- •4 Patients of Shushkarsh having following signs and symptoms.
- •pain (vedana)
- •constipation (baddhkoshta)
- •Sadaha mala pravrutti
- •Gudkandu(Itching at anus)
- •Trushna (Thirst)
- •Agnimandya(Loss of appetite)
- •Daurbalya(Weakness).
- •Alasya(Somnolence)
- •Aruchi(Anorexia)
- •Panduta (anaemia)
排除标准
- •Patients suffering from arsh associated with following disease will be excluded
- •1. History of Hypertension
- •2. History of Immunocompromised, HBsAg, HIV patients
- •3. History of CA Rectum
- •4. History of Diabetes mellitus with metabolic disorders
- •5. 3 & 4 degree Haemorrhoids
- •6. Patient on anticoagulant
研究者
相似试验
尚未招募
2 期
A clinical study to evaluate the effect of oral ayurvedic medication in treatment of renal calculus.CTRI/2023/02/049762Tilak ayurved Mahavidyalaya
已完成
2 期
A clinical trial to study the effects of two drugs, Shatavari Mulaasava and Shatavari Churna in patients suffering from Nidranasha (Insomnia)CTRI/2023/01/049054Dr Ravina Nagesh Dalvi58
尚未招募
2 期
A clinical study to evaluate the effect of ayurvedic application in the treatment of haemorrhoidsCTRI/2023/04/051992Tilak Ayurved Mahavidyalaya
尚未招募
3 期
To study the efficacy of Dhatryadi kwath and Vasadi kwath in management of Vatarakta (Gout).CTRI/2023/08/056963Vd Ravindra Namdev Sagbhor
尚未招募
2 期
A Clinical study to evaluate the effect of local ayurvedic application in the treatment of infected wound.CTRI/2022/12/048541Tilak Ayurved Mahavidyalaya, Pune
